Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1326 | 2617 | 41.1 | 71% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2505 | 3421 | CHRONIC FATIGUE SYNDROME//MULTIPLE CHEMICAL SENSITIVITY//MYALGIC ENCEPHALOMYELITIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHRONIC FATIGUE SYNDROME | Author keyword | 1017 | 70% | 32% | 849 |
2 | MYALGIC ENCEPHALOMYELITIS | Author keyword | 113 | 81% | 3% | 68 |
3 | CHRONIC FATIGUE | Author keyword | 96 | 53% | 5% | 127 |
4 | CHRONIC FATIGUE SYNDROME CFS | Author keyword | 44 | 67% | 2% | 40 |
5 | EXPERT CHRON FATIGUE | Address | 41 | 52% | 2% | 55 |
6 | CFS | Author keyword | 27 | 42% | 2% | 49 |
7 | FATIGUE SYNDROME CHRONIC | Author keyword | 19 | 76% | 0% | 13 |
8 | NEUROIMMUNOL EMERGING DIS | Address | 18 | 89% | 0% | 8 |
9 | MUSCULOSKELETAL PHYSIOTHER Y | Address | 18 | 41% | 1% | 33 |
10 | CFS COOPERAT | Address | 17 | 100% | 0% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHRONIC FATIGUE SYNDROME | 1017 | 70% | 32% | 849 | Search CHRONIC+FATIGUE+SYNDROME | Search CHRONIC+FATIGUE+SYNDROME |
2 | MYALGIC ENCEPHALOMYELITIS | 113 | 81% | 3% | 68 | Search MYALGIC+ENCEPHALOMYELITIS | Search MYALGIC+ENCEPHALOMYELITIS |
3 | CHRONIC FATIGUE | 96 | 53% | 5% | 127 | Search CHRONIC+FATIGUE | Search CHRONIC+FATIGUE |
4 | CHRONIC FATIGUE SYNDROME CFS | 44 | 67% | 2% | 40 | Search CHRONIC+FATIGUE+SYNDROME+CFS | Search CHRONIC+FATIGUE+SYNDROME+CFS |
5 | CFS | 27 | 42% | 2% | 49 | Search CFS | Search CFS |
6 | FATIGUE SYNDROME CHRONIC | 19 | 76% | 0% | 13 | Search FATIGUE+SYNDROME++CHRONIC | Search FATIGUE+SYNDROME++CHRONIC |
7 | ME CFS | 15 | 88% | 0% | 7 | Search ME+CFS | Search ME+CFS |
8 | GRADED EXERCISE THERAPY | 13 | 80% | 0% | 8 | Search GRADED+EXERCISE+THERAPY | Search GRADED+EXERCISE+THERAPY |
9 | UNEXPLAINED ILLNESS | 11 | 100% | 0% | 6 | Search UNEXPLAINED+ILLNESS | Search UNEXPLAINED+ILLNESS |
10 | POSTVIRAL FATIGUE SYNDROME | 9 | 83% | 0% | 5 | Search POSTVIRAL+FATIGUE+SYNDROME | Search POSTVIRAL+FATIGUE+SYNDROME |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POSTVIRAL FATIGUE | 182 | 89% | 3% | 82 |
2 | MYALGIC ENCEPHALOMYELITIS | 178 | 88% | 3% | 83 |
3 | WORKING CASE DEFINITION | 82 | 92% | 1% | 33 |
4 | SYNDROME CFS | 52 | 75% | 1% | 38 |
5 | NEURALLY MEDIATED HYPOTENSION | 45 | 56% | 2% | 55 |
6 | UNEXPLAINED CHRONIC FATIGUE | 44 | 100% | 1% | 16 |
7 | IMMUNE DYSFUNCTION SYNDROME | 41 | 100% | 1% | 15 |
8 | NEURASTHENIA | 33 | 47% | 2% | 52 |
9 | CHRONIC POSTVIRAL FATIGUE | 32 | 85% | 1% | 17 |
10 | UNEXPLAINED FATIGUE | 29 | 71% | 1% | 24 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Myalgic encephalomyelitis: International Consensus Criteria | 2011 | 85 | 96 | 89% |
Chronic fatigue syndrome | 2006 | 204 | 108 | 91% |
Chronic fatigue syndrome: A review | 2003 | 267 | 193 | 83% |
Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop | 2015 | 1 | 58 | 97% |
Interventions for the treatment and management of chronic fatigue syndrome - A systematic review | 2001 | 237 | 38 | 92% |
Exercise therapy for chronic fatigue syndrome | 2015 | 1 | 44 | 80% |
Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop | 2015 | 1 | 51 | 75% |
A systematic review describing the prognosis of chronic fatigue syndrome | 2005 | 110 | 29 | 100% |
Cognitive behaviour therapy for chronic fatigue syndrome in adults | 2008 | 70 | 50 | 82% |
The epidemiology of chronic fatigue syndrome/myalgic encephalitis in children | 2014 | 5 | 45 | 93% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPERT CHRON FATIGUE | 41 | 52% | 2.1% | 55 |
2 | NEUROIMMUNOL EMERGING DIS | 18 | 89% | 0.3% | 8 |
3 | MUSCULOSKELETAL PHYSIOTHER Y | 18 | 41% | 1.3% | 33 |
4 | CFS COOPERAT | 17 | 100% | 0.3% | 8 |
5 | PAIN FATIGUE STUDY | 17 | 75% | 0.5% | 12 |
6 | GOLD COAST PUBL HLTH UNIT | 13 | 80% | 0.3% | 8 |
7 | CHRON FATIGUE CLIN | 12 | 86% | 0.2% | 6 |
8 | CHRON FATIGUE REFERENCE | 11 | 100% | 0.2% | 6 |
9 | TIVOLI UNIV HOSP | 9 | 83% | 0.2% | 5 |
10 | CHRON FATIGUE SYNDROME COOPERAT | 9 | 67% | 0.3% | 8 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000089379 | XMRV//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS XMRV |
2 | 0.0000062883 | FIBROMYALGIA//FIBROMYALGIA SYNDROME//TENDER POINTS |
3 | 0.0000060571 | PERSIAN GULF SYNDROME//GULF WAR ILLNESS//GULF WAR SYNDROME |
4 | 0.0000055895 | POSTURAL TACHYCARDIA SYNDROME//INAPPROPRIATE SINUS TACHYCARDIA//ORTHOSTATIC INTOLERANCE |
5 | 0.0000055218 | HYPOCHONDRIASIS//HEALTH ANXIETY//SOMATOFORM DISORDERS |
6 | 0.0000051037 | CANCER RELATED FATIGUE//SYMPTOM CLUSTER//SYMPTOM CLUSTERS |
7 | 0.0000047046 | MULTIPLE CHEMICAL SENSITIVITY//MULTIPLE CHEMICAL SENSITIVITY MCS//ENVIRONMENTAL ILLNESS |
8 | 0.0000042557 | INFECTIOUS MONONUCLEOSIS//MONONUCLEOSIS//ACUTE EBV INFECTION |
9 | 0.0000042038 | NITROXOLINE//NEWBORNS AT RISK//MYCOPHOBIA |
10 | 0.0000039510 | ANTI FATIGUE//CENTRAL FATIGUE//SEA SNAKE LIPIDS |